Blacklock's Reporter

Health Canada scientific advisory panels are rife with appointees who’ve taken money from pharmaceutical companies, says a Canadian Medical Association Journal author. Conflict rules are so weak the department does not publicly record members’ votes on matters affecting drug sales: “This lack of information is troubling.”